NCT05865678 2024-02-21
SKETCh
The Christie NHS Foundation Trust
Unknown
Clinical Trials
95 trialsNCT06246006 2024-02-07
MPL - NPM
Centre Hospitalier Universitaire de Nīmes
Unknown
NCT06177561 2023-12-20
Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT
Ruijin Hospital
Phase NA Unknown
NCT05692713 2023-12-08
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)
University of British Columbia
Unknown
NCT04372524 2023-12-05
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
University of British Columbia
Unknown
NCT05925660 2023-12-05
MUCOPS
Universitaire Ziekenhuizen KU Leuven
Phase NA Unknown
NCT04663100 2023-12-04
Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
University of Tennessee
Phase NA Unknown
NCT05235633 2023-11-24
ADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin Lymphoma
Technical University of Munich
Unknown
NCT04856215 2023-10-03
RITII
Great Ormond Street Hospital for Children NHS Foundation Trust
Phase 2 Unknown
NCT04504526 2023-09-15
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
NCT01004640 2023-09-14
Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
Alliance for Clinical Trials in Oncology
Unknown
NCT00900224 2023-08-31
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
Unknown
NCT04965649 2023-08-30
TIPHI
Centre Hospitalier Universitaire de Nīmes
Unknown
NCT05932173 2023-07-11
A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Phase 1/2 Unknown
NCT05576532 2023-06-28
Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT02931942 2023-03-16
Changing Over Time of Ascorbic Acid After Chemotherapy
Maastricht University Medical Center
Unknown
NCT03846362 2023-03-16
A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 3 Unknown
NCT05495035 2023-03-02
Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL
Institute of Hematology & Blood Diseases Hospital, China
Phase 1 Unknown
NCT04688021 2023-02-21
A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.
First Affiliated Hospital of Zhejiang University
Phase 2 Unknown
NCT05672420 2023-01-05
Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1/2 Unknown
NCT05649371 2022-12-14
Multiphasic Prehab Allo-HSCT
University of Calgary
Phase NA Unknown
NCT05519384 2022-11-28
Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase EARLY_PHASE1 Unknown
NCT02643888 2022-10-31
Pre-existing Kinase Domain Mutations in Ph-positive Leukemias
St. Anna Kinderkrebsforschung
Unknown
NCT03825367 2022-10-12
Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML
Therapeutic Advances in Childhood Leukemia Consortium
Phase 1/2 Unknown
NCT04033627 2022-09-29
TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia
Shanghai Children's Medical Center
Phase NA Unknown
NCT04684472 2022-09-26
Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies
Sichuan University
Phase 1 Unknown
NCT04352556 2022-09-23
COVID19-hematological Malignancies: the Italian Hematology Alliance
Ospedale di Circolo - Fondazione Macchi
Unknown
NCT05473325 2022-08-15
BRANCH-P
Willows Health
Unknown
NCT03564470 2022-07-01
Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL
Nanfang Hospital, Southern Medical University
Phase 2/3 Unknown
NCT05203809 2022-01-24
THERMAL
Malaghan Institute of Medical Research
Unknown
NCT05164042 2021-12-20
CAR-T
Shenzhen University General Hospital
Phase 1/2 Unknown
NCT04722952 2021-12-03
PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML
The First Affiliated Hospital of Soochow University
Phase 3 Unknown
NCT04014894 2021-11-12
ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1 Unknown
NCT04037189 2021-10-01
Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia
Rabin Medical Center
Unknown
NCT00558519 2021-08-18
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Alliance for Clinical Trials in Oncology
Phase 2 Unknown
NCT00651261 2021-08-18
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
Phase 3 Unknown
NCT03262298 2021-02-09
Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies
Affiliated Hospital to Academy of Military Medical Sciences
Phase 1/2 Unknown
NCT00498719 2020-12-31
Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer
M.D. Anderson Cancer Center
Unknown
NCT04636918 2020-11-19
Ikervis
Singapore Eye Research Institute
Phase 4 Unknown
NCT01064557 2020-10-14
"AIDA" Protocol (LAP 0493)
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase NA Unknown
NCT03759899 2020-10-01
hAECs Are Preliminarily Applied in Allogeneic Hematopoietic Stem Cell Transplantation
Peking University People's Hospital
Unknown
NCT04496011 2020-08-03
Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation
Federal University of Health Science of Porto Alegre
Phase NA Unknown
NCT04406285 2020-05-28
Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent.
Federal University of Health Science of Porto Alegre
Phase NA Unknown
NCT03600558 2020-04-24
Efficacy of FLAG Regimen for the Treatment of Patients With AML
Tianjin Medical University General Hospital
Unknown
NCT04320992 2020-03-26
A Multicenter Prospective Study of "High Risk" Molecular Typing in Patients With Adult T Lymphoblastic Lymphoma
Sun Yat-sen University
Unknown
NCT00525746 2020-01-14
Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)
M.D. Anderson Cancer Center
Unknown
NCT01046305 2020-01-07
Symptom Burden in Chronic Myeloid Leukemia (CML)
M.D. Anderson Cancer Center
Unknown
NCT03836690 2019-10-25
ToTem
University College, London
Phase 1 Unknown
NCT04074213 2019-08-30
CLOZARIX
University Hospital, Caen
Unknown
NCT04043676 2019-08-02
Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia
Fundación Teófilo Hernando, Spain
Phase 2 Unknown